Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05685368 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease

Study acronym: ACT for SCD
StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Aug 28, 2023 to Apr 1, 2025
    • Collaborators expanded, about 10 words
    v7
  2. Phase: Not applicable to Phase 1/2v6 Show 7 more changesShow less
    • Enrollment target: 30 to 66
    • Primary and study completion dates: Jul 31, 2024 to Jun 30, 2029
    • Primary endpoints: 1 to 4
    • Interventions: ACT for Race Related Stress (Behavioral) to ACT for SCD (Behavioral)
    • Eligibility criteria expanded, about 232 words
    • Study arms: 1 to 2
    • Study title shortened, about 2 words
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 1, 2023 to Aug 28, 2023
    • Secondary endpoints: details revised at 4 of 4 entries
    • Site details revised
    v5
  4. Start date: Jun 1, 2023 to Aug 1, 2023v4
  5. Re-verified, no change to tracked fieldsv3
  6. Start date: Mar 1, 2023 to Jun 1, 2023
    • Primary endpoint revised
    • Secondary endpoints revised (4)
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The current study seeks to build on previous research that demonstrates the efficacy of Acceptance and Commitment Therapy in combating stigma by investigating the feasibility and acceptability of a protocol to support Black adolescents and young adults in coping with race related stress. The study will consist of a small, purposeful, non-randomized sample (N = 30) of clients enrolled into a 10-session Acceptance and Commitment Therapy group. The group will be offered as part of regular clinical care at the Division of Adolescent and Young Adult Medicine. Three consecutive groups will be run with approximately 8-10 participants in each group over the next year.
Trial Details
NCT Number NCT05685368
Lead Sponsor Children's Hospital Los Angeles
Collaborators: University of Southern California & Children's Hospital Los Angeles (USC-CHLA)
Conditions
(from sponsor)		 Race-related Stress, Depression, Anxiety, Quality of Life, Stress Reaction
Related terms Anxiety Disorders, Depression, Fractures, Stress
Enrollment 66 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov